E. Rutgers

发表

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

Jane E. Carpenter, Jaana M. Hartikainen, Sandra L. Halverson, 2015, JNCI Journal of the National Cancer Institute.

Relevant impact of central pathology review on nodal classification in individual breast cancer patients.

P. V. van Diest, P. Bult, C. Seynaeve, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical application of the 70-gene profile: the MINDACT trial.

L. V. van't Veer, S. Loi, S. Mook, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

H. D. de Koning, J. Klijn, R. Tollenaar, 2004, The New England journal of medicine.

Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial

N. Aaronson, H. Valdimarsdottir, S. Verhoef, 2015, Genetics in Medicine.

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

Harry J de Koning, Mieke Kriege, Carla Boetes, 2006, Cancer.

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

Michael Hauptmann, Stella Mook, L. J. Veer, 2010, Breast Cancer Research and Treatment.

Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

L. Murrer, J. Peterse, F. Stewart, 1997, British Journal of Cancer.

Single Intralesional Tracer Dose for Radio-Guided Excision of Clinically Occult Breast Cancer and Sentinel Node

E. Rutgers, E. Deurloo, P. Tanis, 2001, Annals of Surgical Oncology.

Association analysis identifies 65 new breast cancer risk loci

Gary D Bader, Jaana M. Hartikainen, Jeffery M. Meyer, 2017, Nature.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

R. Mansel, E. Rutgers, J. Bogaerts, 2014, The Lancet. Oncology.

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients

E. Rutgers, K. Gilhuijs, M. Schot, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.

E. Rutgers, K. Gilhuijs, W. Vogel, 2010, European journal of cancer.

Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla

S. Rodenhuis, E. Rutgers, J. Wesseling, 2013, Annals of Surgical Oncology.

Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II–III breast cancer patients treated with neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, P. Elkhuizen, 2013, Breast Cancer Research and Treatment.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

J. Cuzick, A. Tutt, C. Denkert, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.

P. V. van Diest, E. Rutgers, J. V. van Dijck, 2008, European journal of cancer.

The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.

J. Peterse, E. Rutgers, L. Broekhuizen, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.

L. V. van't Veer, A. Glas, M. Delorenzi, 2017, European journal of cancer.

Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer

E. Rutgers, J. Wesseling, V. van der Noort, 2016, Clinical nuclear medicine.

Conservative surgery for multifocal/multicentric breast cancer.

E. Rutgers, M. Nijenhuis, 2015, Breast.

Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis.

Kenneth G A Gilhuijs, J. Peterse, E. Rutgers, 2005, European journal of cancer.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

H. D. de Koning, E. Heijnsdijk, C. Seynaeve, 2012, BMC Cancer.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Harry J de Koning, Madeleine M A Tilanus-Linthorst, Mieke Kriege, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?

I. Ellis, C. Kuhl, S. Lakhani, 2006, European journal of cancer.

Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage

E. Rutgers, P. Tanis, O. Nieweg, 2001, Nuclear medicine communications.

The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials.

E. Rutgers, R. L. Bourez, 2001, Surgical oncology clinics of North America.

Lymphatic Drainage Patterns From the Breast

E. Rutgers, O. Nieweg, R. V. Valdés Olmos, 2004, Annals of surgery.

The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.

A. Hart, E. Rutgers, R. Kaas, 2005, Breast.

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

A. Hart, J. Peterse, E. Rutgers, 2003, British Journal of Cancer.

Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer.

M. J. van de Vijver, S. Rodenhuis, L. Wessels, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast

E. Rutgers, F. V. van Leeuwen, J. Gietema, 2014, Journal of the National Cancer Institute.

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.

A. Glas, C. Sotiriou, M. Delorenzi, 2021, The Lancet. Oncology.

Status of Lymph Node Staging

E. Rutgers, E. Deurloo, O. Nieweg, 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

Limb-sparing therapy of extremity soft tissue sarcomas: treatment outcome and long-term functional results.

A. Hart, E. Rutgers, R. Keus, 1994, European journal of cancer.

Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers: Very Low Risk for Subsequent Breast Cancer

S. Verhoef, E. Rutgers, J. Wesseling, 2010, Annals of surgery.

The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma.

E. Rutgers, L. S. Schultze Kool, P. Baas, 2003, The Annals of thoracic surgery.

Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes

J. Peterse, E. Rutgers, H. Oldenburg, 2006, Cancer.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

E. Winer, J. Cuzick, A. Tutt, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Five-year results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial.

H. Bartelink, E. Rutgers, J. Wesseling, 2020, International journal of radiation oncology, biology, physics.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

E. Winer, J. Cuzick, A. Tutt, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy

E. Rutgers, M. Straver, M. V. Vrancken Peeters, 2017, The British journal of surgery.

Radiotherapy or surgery for the axilla in node-positive breast cancer?--authors' reply.

E. Rutgers, L. Slaets, M. Donker, 2015, The Lancet. Oncology.

Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes.

E. Rutgers, S. Siesling, P. Peeters, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome.

R. Mansel, E. Rutgers, S. Litière, 2013, European journal of cancer.

Sentinel Node and Recurrent Breast Cancer (SNARB): Results of a Nationwide Registration Study

E. Rutgers, G. Nieuwenhuijzen, R. Roumen, 2013, Annals of Surgical Oncology.

Breast Cancer Patients with Extra-Axillary Sentinel Nodes Only may be Spared Axillary Lymph Node Dissection

I. V. D. van der Ploeg, E. Rutgers, P. Tanis, 2008, Annals of Surgical Oncology.

Should the Hunt for Internal Mammary Chain Sentinel Nodes Begin? An Evaluation of 150 Breast Cancer Patients

E. Rutgers, P. Tanis, O. Nieweg, 2003, Annals of Surgical Oncology.

Intratumoral Versus Intraparenchymal Injection Technique for Lymphoscintigraphy in Breast Cancer

E. Rutgers, O. Nieweg, R. V. Valdés Olmos, 2003, Clinical nuclear medicine.

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients

J. Peterse, E. Rutgers, E. Rutgers, 2002, British Journal of Cancer.

Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer

E. Rutgers, P. Tanis, O. Nieweg, 2006, Journal of surgical oncology.

The Value of Ipsilateral Breast Tumor Recurrence as a Quality Indicator: Hospital Variation in the Netherlands

E. Rutgers, S. Siesling, P. Peeters, 2015, Annals of Surgical Oncology.

Sentinel Node Biopsy and Concomitant Probe-Guided Tumor Excision of Nonpalpable Breast Cancer

E. Rutgers, H. Oldenburg, P. Tanis, 2007, Annals of Surgical Oncology.

Non‐axillary breast cancer recurrences after sentinel node biopsy

E. Rutgers, O. Nieweg, B. Kroon, 2005, Journal of surgical oncology.

Technique of sentinel node biopsy in breast cancer.

E. Rutgers, O. Nieweg, B. Kroon, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lymphatic Drainage Patterns in Breast Cancer Patients Who Previously Underwent Mantle Field Radiation

E. Rutgers, H. Oldenburg, O. Nieweg, 2009, Annals of Surgical Oncology.

Immediate breast reconstruction with a myocutaneous latissimus dorsi flap and implant following skin-sparing salvage mastectomy after irradiation as part of breast-conserving therapy.

E. Rutgers, J. Hage, M. A. van Huizum, 2016, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Lymphatic Drainage Patterns from the Treated Breast

E. Rutgers, H. Oldenburg, O. Nieweg, 2010, Annals of Surgical Oncology.

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.

M. J. van de Vijver, J. Peterse, J. Coebergh, 2005, European journal of cancer.

Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse

E. Rutgers, H. van Tinteren, M. Stokkel, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Breast conservation for the very young?

E. Rutgers, P. Elkhuizen, 2009, Breast.

Increased risk of breast cancer development after diagnosis of salivary gland tumour.

E. Rutgers, A. Balm, I. B. Tan, 2005, European journal of cancer.

Port site metastasis as a complication of thoracoscopic metastatectomy.

E. Rutgers, E. Mutsaerts, F. Zoetmulder, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

preoperative assessment of patients with malignant pleural mesothelioma The value of chest computer tomography and cervical mediastinoscopy in the

E. Rutgers, N. Zandwijk, F. Zoetmulder, 2013 .

FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series

E. Rutgers, W. Vogel, M. V. Vrancken Peeters, 2011, Annals of Nuclear Medicine.

Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients’ and health professionals’ attitudes, experiences, and evaluation of effects on treatment decision making

N. Aaronson, S. Verhoef, E. Rutgers, 2017, Journal of surgical oncology.

7 Relevance of Breast Cancer Subtypes in Response Monitoring with 18F-FDG PET/CT During Neoadjuvant Chemotherapy

S. Rodenhuis, E. Rutgers, K. Gilhuijs, 2012 .

Is prophylactic mastectomy justified in women without BRCA mutation?

E. Rutgers, 2019, Breast.

The prognostic significance of a previous malignancy in operable non-small cell lung cancer.

A. Hart, E. Rutgers, P. Baas, 2001, Lung cancer.

newly diagnosed breast cancer patients : Design of a multicenter clinical trial

Hogervorst, Frans, Rob, 2010 .

Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy.

E. Rutgers, H. Willemsen, R. Kaas, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation.

J. Peterse, H. Bartelink, E. Rutgers, 1993, European journal of cancer.

Reproducibility of the assessment of tumor extent in the breast using multiple image modalities.

H. Bartelink, E. Rutgers, E. Deurloo, 2003, Medical physics.

Staging of Breast Cancer with 18F-FDG PET and PET/CT

E. Rutgers, W. Vogel, R. Olmos, 2009 .

Future prospects for the staging of breast cancer.

E. Rutgers, H. Peterse, 1998, Seminars in surgical oncology.

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer

L. V. van't Veer, A. Glas, E. Rutgers, 2016, Breast Cancer Research and Treatment.

Skin-Sparing Mastectomy and Immediate Breast Reconstruction by Use of Implants: An Assessment of Risk Factors for Complications and Cancer Control in 120 Patients

E. Rutgers, C. M. van der Horst, M. Smeulders, 2006, Plastic and reconstructive surgery.

Chest wall resection in the treatment of locally recurrent breast carcinoma

E. Rutgers, F. Zoetmulder, I. Faneyte, 1997, Cancer.

Cardiovascular morbidity and mortality in patients treated for ductal carcinoma in situ of the breast.

E. Rutgers, F. V. van Leeuwen, J. Gietema, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

R. Tollenaar, A. Stiggelbout, M. Schmidt, 2017, European journal of cancer.

Effects of Lycopene on the Insulin-Like Growth Factor (IGF) System in Premenopausal Breast Cancer Survivors and Women at High Familial Breast Cancer Risk

L. V. van't Veer, D. Voskuil, S. Verhoef, 2008, Nutrition and cancer.

Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members.

N. Aaronson, E. Rutgers, C. V. van Asperen, 1997, Patient education and counseling.

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

R. Tollenaar, N. Aaronson, M. Hooning, 2015, Familial Cancer.

Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

J. Coebergh, E. Rutgers, H. Peterse, 1999, Cancer.

The Hamburg statement: the partnership driving the European agenda on breast cancer.

M. Piccart, E. Rutgers, J. Jassem, 2004, European Journal of Cancer.

Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control

A. Hart, E. Rutgers, F. van Coevorden, 1994, Cancer.

Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancer

I. V. D. van der Ploeg, E. Rutgers, P. Elkhuizen, 2019, Nuclear medicine communications.

Isolated internal mammary sentinel lymph node metastasis in two breast cancer patients

E. Rutgers, P. Tanis, O. Nieweg, 2002, International Journal of Clinical Oncology.

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

S. Rodenhuis, E. Rutgers, S. Linn, 2008, Nederlands tijdschrift voor geneeskunde.

Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern?

E. Rutgers, H. Oldenburg, P. Borgstein, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes

I. V. D. van der Ploeg, E. Rutgers, M. Stokkel, 2019, Journal of surgical oncology.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

E. Winer, J. Cuzick, A. Tutt, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands

E. Rutgers, P. Westenend, P. Peeters, 2011, Breast Cancer Research and Treatment.

Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective Removal

E. Rutgers, H. Oldenburg, P. Elkhuizen, 2018, Annals of Surgical Oncology.

Internal Mammary Chain Drainage of Breast Cancer

E. Rutgers, O. Nieweg, R. Olmos, 2004 .

Optimal breast cancer pathology manifesto.

T. Tot, E. Rutgers, G. Viale, 2015, European journal of cancer.

Thoracoscopic ligation of a thoracic duct leakage.

E. Rutgers, P. Baas, F. Zoetmulder, 1994, Chest.

The NABON breast cancer audit; quality improvement in three years' time

A. Jager, E. Rutgers, P. Westenend, 2014 .

[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"].

M. Tuut, B. Garssen, E. Rutgers, 2002, Nederlands tijdschrift voor geneeskunde.

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy.

A. Hart, H. Bartelink, E. Rutgers, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Prospective Assessment of Surgical Risk Factors in 400 Cases of Skin-Sparing Mastectomy and Immediate Breast Reconstruction with Implants to Establish Selection Criteria

E. Rutgers, J. Hage, L. Woerdeman, 2007, Plastic and reconstructive surgery.

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.

S. Verhoef, E. Rutgers, M. Ausems, 2010, European journal of cancer care.

Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer

E. Rutgers, O. Nieweg, R. Olmos, 2000, The British journal of surgery.

Lymphatic mapping and sentinel node biopsy

E. Rutgers, O. Nieweg, B. Kroon, 1997 .

Sentinel Node Biopsy Before Neoadjuvant Chemotherapy Spares Breast Cancer Patients Axillary Lymph Node Dissection

E. Rutgers, H. Oldenburg, O. Nieweg, 2006, Annals of Surgical Oncology.

Radioguided occult lesion localisation (ROLL) in breast-conserving surgery after neoadjuvant chemotherapy.

E. Rutgers, J. Wesseling, G. Sonke, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Outcome of patients with an ultralow risk 70-gene signature in the MINDACT trial.

A. Witteveen, A. Glas, M. Schmidt, 2021 .

Lymphatic mapping with tracer administration into the primary breast cancer.

E. Rutgers, O. Nieweg, B. Kroon, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela

E. Rutgers, H. Peterse, L. Strobbe, 2004, Breast Cancer Research and Treatment.

Nipple-sparing mastectomy in breast cancer: a viable option?

E. Rutgers, H. Cense, J. V. van Lanschot, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Reproducibility study of lymphoscintigraphy: Excisional biopsy of breast lesions changes drainage patterns

E. Rutgers, O. Nieweg, B. Kroon, 2004, Annals of Surgical Oncology.

Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study

M. Hauptmann, M. Hooning, A. Jager, 2020, Breast Cancer Research and Treatment.

Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy for Stage I Malignant Pleural Mesothelioma

E. Rutgers, P. Baas, R. Haas, 2003, Annals of Surgical Oncology.

The hidden sentinel node in breast cancer: Reevaluating the role of SPECT/CT and tracer reinjection.

E. Rutgers, W. Vogel, M. Stokkel, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Quality control in the locoregional treatment of breast cancer.

E. Rutgers, E. Rutgers, 2001, European journal of cancer.

Factors affecting sensitivity and specificity of screening mammography and MRI in women with a hereditary risk for breast cancer

Brekelmans, J. Klijn, E. Rutgers, 2006 .

444 The EORTC 10041/BIG 03–04 MINDACT trial is feasible: first results of the pilot phase

M. Piccart, L. V. Veer, E. Rutgers, 2010 .

A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy.

A. Hart, J. Peterse, E. Rutgers, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clear cell sarcoma (malignant melanoma) of soft parts

J. Peterse, E. Rutgers, A. A. Hart, 1999, Cancer.

Dermatofibrosarcoma protuberans: treatment and prognosis.

E. Rutgers, B. Kroon, B. Kroon, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Carcinoma arising in thyroglossal remnants.

E. Rutgers, F. Hilgers, B. Loftus, 1994, Clinical otolaryngology and allied sciences.

Breast‐conserving therapy for paget disease of the nipple

J. Peterse, E. Rutgers, J. Julien, 2001, Cancer.

Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?

J. Peterse, E. Rutgers, F. van Coevorden, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

Patrick Neven, Michael Jones, Wei Lu, 2013, Nature Genetics.

Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial

Laurent Jacob, Anke Witteveen, Inès Beumer, 2020, Communications Biology.

Identification and biopsy of the sentinel lymph node in breast cancer.

A. Hart, E. Rutgers, J. V. Dongen, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Summary of the Second International Sentinel Node Conference

E. Rutgers, P. Tanis, O. Nieweg, 2001, European Journal of Nuclear Medicine.

Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.

J. Peterse, E. Rutgers, H. Oldenburg, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.

E. Rutgers, P. Baas, N. van Zandwijk, 2002, Chest.

Gene expression profiling: decoding breast cancer.

A. Glas, E. Rutgers, R. Bender, 2009, Surgical oncology.

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ

M. Schmidt, E. Rutgers, J. Wesseling, 2017, Annals of surgery.

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

M. Schmidt, E. Rutgers, J. Wesseling, 2016, Breast Cancer Research and Treatment.

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

E. Rutgers, J. Wesseling, R. Pijnappel, 2015, European journal of cancer.

Incidence, clinical features, and outcomes of special types in breast cancer in a single institution population

E. Rutgers, R. Vink, E. Kouwenhoven, 2020, The breast journal.

Will we need lymph node dissection at all in the future?

E. Rutgers, C. J. van de Velde, R. L. Bourez, 2002, Clinical breast cancer.

Long-term prognosis of breast cancer: an analysis of 462 patients in a general hospital in south east Netherlands.

J. Coebergh, W. Hop, E. Rutgers, 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).

E. Rutgers, J. Wesseling, E. Lips, 2017, Breast.

Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk

Halverson, Kristen S Purrington, M. Beckmann, 2014 .

Current approach of the axilla in patients with early-stage breast cancer

E. Rutgers, E. Mamounas, G. Minckwitz, 2017, The Lancet.

Micrometastases or isolated tumor cells and the outcome of breast cancer.

P. V. van Diest, P. Bult, C. Seynaeve, 2009, The New England journal of medicine.

Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?

E. Rutgers, E. Kouwenhoven, A. Moorman, 2021, Annals of Surgical Oncology.

Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.

E. Rutgers, S. Linn, A. Francken, 2013, Breast.

Lymphoscintigraphy of the axilla with aspecific colloids and monoclonal antibodies

E. Rutgers, I. Liem, C. Hoefnagel, 1995 .

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.

N. Karssemeijer, H. D. de Koning, R. Tollenaar, 2019, The Lancet. Oncology.

The prognostic significance of the axillary apex biopsy in clinically operable breast cancer.

A. Hart, H. Bartelink, E. Rutgers, 1995, European journal of cancer.

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, J. Wesseling, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

Annuska M. Glas, A. Glas, S. Rodenhuis, 2010, Breast Cancer Research and Treatment.

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Local recurrence after breast conservation therapy for early stage breast carcinoma

J. Coebergh, E. Rutgers, H. Peterse, 1999 .

Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer

H. D. de Koning, J. Klijn, R. Tollenaar, 2006, Breast Cancer Research and Treatment.

Chylous Fistula after Internal Mammary Chain Sentinel Node Biopsy

E. Rutgers, S. van der Meij, P. Tanis, 2010, The American surgeon.

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

J. Peterse, S. Rodenhuis, J. Baars, 1998, The Lancet.

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Stella Mook, Fatima Cardoso, S. Mook, 2007, Cancer genomics & proteomics.

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.

J Bogaerts, A. Glas, E. Rutgers, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.

M. J. van de Vijver, A. Hart, H. Bartelink, 2008, International journal of radiation oncology, biology, physics.

Lymphatic mapping and sentinel lymph node biopsy in breast cancer

Liesbeth Jansen, Renato A. Valdés Olmos, Omgo E. Nieweg, 1999, European Journal of Nuclear Medicine.

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study.

E. Rutgers, S. Linn, J. Wesseling, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.

E. Rutgers, J. Bogaerts, F. Cardoso, 2011, European journal of cancer.

MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.

E. Rutgers, F. Cardoso, G. Viale, 2020 .

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

S. Mook, M. Schmidt, E. Rutgers, 2009, The Lancet. Oncology.

Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.

Gustavo Werutsky, Saskia Litière, Jan Bogaerts, 2012, The Lancet. Oncology.

CBO-richtlijn 'Behandeling van het mammacarcinoom', Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"

M. Tuut, B. Garssen, E. Rutgers, 2002 .

Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature

L. J. Veer, S. Mook, E. Rutgers, 2010, Annals of Surgical Oncology.

Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.

P. V. van Diest, E. Rutgers, P. Peeters, 2015, European journal of cancer.

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.

M. Piccart, E. Rutgers, S. Litière, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS.

I. Fentiman, E. Rutgers, L. Duchateau, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ—A Nested Case–Control Study

M. Schmidt, E. Rutgers, J. Wesseling, 2018, Clinical Cancer Research.

Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping

H. Bartelink, L. Pusztai, J. Reis-Filho, 2012, The breast journal.

Adjuvant therapy in stage I carcinoma of the breast

H. Bartelink, L. Pusztai, G. Schwartz, 2012, Cancer.

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

A. Broeks, R. Tollenaar, M. Schmidt, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radioactive Seed Localization of Breast Lesions: An Adequate Localization Method without Seed Migration

Kenneth G A Gilhuijs, Tanja Alderliesten, Claudette E Loo, 2011, The breast journal.

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

A. Glas, E. Rutgers, E. Rutgers, 2017, Breast Cancer Research and Treatment.

P1-07-06: High Concordance of Protein (by IHC), Gene (by FISH; HER-2 Only) and Microarray Readout (by TargetPrint) of ER/PR/HER2: Results from the MINDACT Trial.

A. Glas, M. Piccart, E. Rutgers, 2011 .

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.

A. Glas, E. Rutgers, J. Bogaerts, 2014 .

Ultrasonography and Fine-Needle Aspiration Cytology Can Spare Breast Cancer Patients Unnecessary Sentinel Lymph Node Biopsy

J. Peterse, E. Rutgers, E. Deurloo, 2006, Annals of Surgical Oncology.

Is Lymphatic Mapping in Breast Cancer Adequate and Safe?

J. Peterse, E. Rutgers, O. Nieweg, 2001, World Journal of Surgery.

The Additional Value of SPECT/CT in Lymphatic Mapping in Breast Cancer and Melanoma

I. V. D. van der Ploeg, E. Rutgers, O. Nieweg, 2007, Journal of Nuclear Medicine.

Frozen Section Investigation of the Sentinel Node in Malignant Melanoma and Breast Cancer

Omgo E. Nieweg, J. Peterse, E. Rutgers, 2001, Annals of Surgical Oncology.

Guidelines to assure quality in breast cancer surgery.

E. Rutgers, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy.

Roland Holland, Claudette E Loo, Harry Bartelink, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lymphatic mapping with intralesional tracer administration in breast carcinoma patients

E. Rutgers, D. Piers, O. Nieweg, 2000, Cancer.

Long term survival of thoracoscopic metastasectomy vs metastasectomy by thoracotomy in patients with a solitary pulmonary lesion.

A. Hart, E. Rutgers, P. Baas, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy.

A. Hart, E. Rutgers, P. Baas, 2001, The Annals of thoracic surgery.

Validation of gamma probe detection of the sentinel node in melanoma.

S H Muller, E. Rutgers, I. Liem, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.

S H Muller, E. Rutgers, O. Nieweg, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft Tissue Tumours Working Group.

H. Bartelink, E. Rutgers, F. van Coevorden, 1997, European journal of cancer.

The sentinel node biopsy in patients with breast cancer; many controversies remain.

E. Rutgers, H. Oldenburg, O. Nieweg, 2006, European journal of gynaecological oncology.

What is a false‐negative result for sentinel node procedures in breast cancer?

E. Rutgers, O. Nieweg, B. Kroon, 2003, Journal of surgical oncology.

Intra-operative staging of the axilla in operable breast cancer

E. Rutgers, G. Tienhoven, O. Nieweg, 1995 .

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

H. D. de Koning, R. Tollenaar, E. Heijnsdijk, 2013, Journal of the National Cancer Institute.

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

Julian Peto, Kyriaki Michailidou, Thomas Brüning, 2014, Human molecular genetics.

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

Kristen S Purrington, Ali Amin Al Olama, S. Cross, 2014, Human molecular genetics.

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Matthias W. Beckmann, Peter A. Fasching, Nur Aishah Mohd Taib, 2014, Nature Communications.

Tailored Surgery for Early Breast Cancer: Biological Aspects

E. Rutgers, 2006 .

Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)

M. J. van de Vijver, J. Peterse, J. Coebergh, 1999, European journal of cancer.

Response to preoperative radiotherapy in relation to gene expression patterns in breast cancer patients.

M. J. van de Vijver, H. Bartelink, E. Rutgers, 2017, International journal of radiation oncology, biology, physics.

Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)

Marie-Christine W. Gast, E. Rutgers, J. Schellens, 2009, Clinical chemistry and laboratory medicine.

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

M. J. van de Vijver, J. Peterse, E. Rutgers, 2007, British Journal of Cancer.

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

E. Rutgers, J. Wesseling, H. Oldenburg, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients

J. Peterse, H. Bartelink, E. Rutgers, 2006, European Radiology.

Breast-conserving therapy for invasive carcinoma: diagnosis of local recurrence.

J. Peterse, E. Rutgers, J. Borger, 1991, The Netherlands journal of surgery.

Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study

E. Rutgers, K. Aalders, S. Elias, 2015, Annals of Surgical Oncology.

Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy

A. Hart, J. Peterse, E. Rutgers, 1999, Cancer.

Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.

E. Rutgers, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results

E. Rutgers, J. Wesseling, E. Deurloo, 2010, Breast Cancer Research and Treatment.

The effect of margins on the clinical management of ductal carcinoma in situ of the breast

E. Rutgers, K. Gilhuijs, P. Meijnen, 2008, Journal of surgical oncology.

Clinical Outcome after Selective Treatment of Patients Diagnosed with Ductal Carcinoma In Situ of the Breast

J. Peterse, H. Bartelink, E. Rutgers, 2007, Annals of Surgical Oncology.

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study

Marjanka K. Schmidt, M. Schmidt, E. Rutgers, 2017, Breast Cancer Research.

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

A. Hart, I. Fentiman, E. Rutgers, 2002, British Journal of Cancer.

Ductal Carcinoma in Situ of the Breast; Diagnostic Assessment and Treatment

J. Peterse, E. Rutgers, N. Bijker, 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS

A. Broeks, M. Schmidt, E. Rutgers, 2019, The American journal of surgical pathology.

Independent prognostic value of screen detection in invasive breast cancer.

S. Mook, M. Schmidt, E. Rutgers, 2011, Journal of the National Cancer Institute.

Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute.

M. J. van de Vijver, H. Bartelink, E. Rutgers, 2016, Breast.

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes

S. Rodenhuis, E. Rutgers, J. Wesseling, 2017, PloS one.

Ductal carcinoma in situ of the breast – an overview of the randomized clinical trials

E. Rutgers, P. Meijnen, 2004 .

Sentinel node procedure in breast carcinoma: a valid tool to omit unnecessary axillary treatment or even more?

E. Rutgers, 2004, European journal of cancer.

The intraoperative assessment of sentinel nodes - Standards and controversies.

E. Rutgers, M. V. Vrancken Peeters, M. V. D. van der Noordaa, 2017, Breast.

Who should not undergo breast conservation?

E. Rutgers, M. Nijenhuis, 2013, Breast.

The impact of the CUSA ultrasonic dissection device on major liver resections.

E. Rutgers, F. Zoetmulder, E. Gortzak, 1991, The Netherlands journal of surgery.

Axillary and Extra-axillary Lymph Node Recurrences after a Tumor-Negative Sentinel Node Biopsy for Breast Cancer Using Intralesional Tracer Administration

I. V. D. van der Ploeg, E. Rutgers, O. Nieweg, 2008, Annals of Surgical Oncology.

Intraoperative 3D Navigation for Single or Multiple 125I-Seed Localization in Breast-Preserving Cancer Surgery

E. Rutgers, M. V. Vrancken Peeters, M. Stokkel, 2016, Clinical nuclear medicine.

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.

H. D. de Koning, R. Tollenaar, E. Heijnsdijk, 2020, JAMA oncology.

Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, J. Wesseling, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer.

S. Rodenhuis, E. Rutgers, J. Wesseling, 2013, Breast.

Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, J. Wesseling, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, P. Elkhuizen, 2012, Breast Cancer Research and Treatment.

Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.

S. Rodenhuis, E. Rutgers, J. Wesseling, 2009, European journal of cancer.

First results of the preoperative accelerated partial breast irradiation (PAPBI) trial.

Harry Bartelink, Corine van Vliet-Vroegindeweij, M. J. van de Vijver, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast cancer and pregnancy: diagnosis and treatment options

E. Rutgers, G. Sonke, E. A. Velde, 2009 .

150O_PRNot all small node negative (pT1abN0) breast cancers are similar: Outcome results from an EORTC 10041/BIG 3-04 (MINDACT) trial substudy

M. Piccart, E. Rutgers, J. Bogaerts, 2017 .

Prognosis of acute coronary syndromes after radiotherapy for breast cancer.

A. Maas, M. Hooning, C. Seynaeve, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer

S. Darby, M. Hauptmann, M. Hooning, 2018, British Journal of Cancer.

Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methods.

Rami Nachabé, Marjolein van der Voort, Benno H W Hendriks, 2011, Journal of biomedical optics.

Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.

D. Rietveld, E. Rutgers, J. Theuws, 2016, International journal of radiation oncology, biology, physics.

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy.

H. Bartelink, M. A. van den Bosch, W. Mali, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience

E. Rutgers, J. Wesseling, E. van Werkhoven, 2021, Annals of Surgical Oncology.

Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study

P. V. van Diest, E. Rutgers, J. Wesseling, 2018, Genes.

Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: A 10-year single-institute experience

A. Hart, E. Rutgers, F. Coevorden, 2005, Journal of Gastrointestinal Surgery.

Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer.

E. Rutgers, G. Sonke, M. V. Vrancken Peeters, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

L. Boersma, E. Rutgers, J. Maduro, 2023, Breast Cancer Research and Treatment.

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study

E. Rutgers, P. Westenend, S. Linn, 2015, Genetics in Medicine.

Interpretive Review : Feasibility and Effects of Decision Aids

E. Rutgers, Sjaak Molenaar, Mirjam A.G. Sprangers, 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

S. Rodenhuis, E. Rutgers, S. Linn, 2010, Annals of Surgical Oncology.

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

R. Warren, H. D. de Koning, J. Klijn, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Avoiding preoperative breast MRI when conventional imaging is sufficient to stage patients eligible for breast conserving therapy.

E. Rutgers, J. Wesseling, K. Gilhuijs, 2014, European journal of radiology.

Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes

A. Hart, J. Peterse, F. Hoebers, 2000, Cancer.

Low cause-specific mortality in women treated for ductal carcinoma in situ of the breast

M. Schmidt, E. Rutgers, F. Leeuwen, 2017 .

Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists' group (BOOG)

P. Bult, C. Seynaeve, E. Rutgers, 2009 .

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer

S. Darby, M. Hauptmann, M. Hooning, 2018, British Journal of Cancer.

Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

J. Coebergh, J. Klijn, E. Rutgers, 1998, European journal of cancer.

10 years follow up of the RASTER study: implementing a genomic signature in daily practice

E. Rutgers, S. Linn, J. Wesseling, 2017 .

Eight false negative sentinel node procedures in breast cancer: what went wrong?

J. Peterse, E. Rutgers, O. Nieweg, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator].

E. Rutgers, S. Siesling, P. Peeters, 2010, Nederlandsch tijdschrift voor geneeskunde.

Radio-immunotargeting in colorectal carcinoma.

E. Rutgers, E J Rutgers, 1995, European journal of cancer.

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study

M. Schmidt, E. Rutgers, J. Wesseling, 2017, Breast Cancer Research.

PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.

S. Rodenhuis, E. Rutgers, P. Elkhuizen, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer

E. Rutgers, F. van der Leij, P. Elkhuizen, 2014, Acta oncologica.

Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area.

E. Rutgers, S. Siesling, T. van Dalen, 2017, European journal of cancer.

Factors Associated with the Use of Gene Expression Profiles in Estrogen Receptor-Positive Early-Stage Breast Cancer Patients: A Nationwide Study

E. Rutgers, S. Siesling, T. van Dalen, 2016, Public Health Genomics.

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.

R. Tollenaar, M. Schmidt, E. Rutgers, 2019, Annals of surgery.

Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

S. Rodenhuis, E. Rutgers, J. Wesseling, 2017, Cancer Imaging.

Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.

J. Peterse, E. Rutgers, O. Nieweg, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast cancer: questions for future trials.

E. Rutgers, E J Rutgers, 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Is axillary lymph node clearance required in node-positive breast cancer?

E. Rutgers, N. Bundred, M. Donker, 2015, Nature Reviews Clinical Oncology.

Early detection of breast and ovarian cancer in families with BRCA mutations.

E. Rutgers, J. Oosterwijk, L. Beex, 2005, European journal of cancer.

Sentinel-lymph-node biopsy in breast cancer.

E. Rutgers, 2007, The Lancet. Oncology.

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET

R. A. Valdés Olmos, E. Rutgers, C. Loo, 2012, Journal of oncology.

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques

S. Rodenhuis, E. Rutgers, H. Oldenburg, 2011, Breast Cancer Research and Treatment.

Stage of breast cancers found during the surveillance of women with a familial or hereditary risk.

A. Hart, E. Rutgers, S. Muller, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Abstract P4-11-08: Pathological assessment of discordant cases for molecular (BluePrint and MammaPrint) vs clinical subtypes for breast cancer, among 6,694 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial

E. Rutgers, J. Bogaerts, F. Cardoso, 2012 .

MRI of the breast in patients with DCIS to exclude the presence of invasive disease

E. Rutgers, J. Wesseling, E. Deurloo, 2012, European Radiology.

Changes in gene expression profiling due to primary chemotherapy in patients with locally advanced breast cancer

A. Witteveen, S. Rodenhuis, E. Rutgers, 2004 .

Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.

E. Rutgers, J. Wesseling, V. van der Noort, 2016, AJR. American journal of roentgenology.

SELDI-TOF MS serum protein profiles in breast cancer: assessment of robustness and validity.

Marie-Christine W. Gast, E. Rutgers, J. Schellens, 2006, Cancer biomarkers : section A of Disease markers.

Diffuse reflectance spectroscopy: towards clinical application in breast cancer

Benno H. W. Hendriks, Theo J. M. Ruers, Gerald W. Lucassen, 2012, Breast Cancer Research and Treatment.

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

L. J. Veer, M. Hauptmann, S. Mook, 2010, Breast Cancer Research and Treatment.

Establishing cost-effectiveness of genetic targeting of cancer therapies

E. Rutgers, M. Joore, V. Retèl, 2008 .

[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].

J. Peterse, E. Rutgers, O. Nieweg, 2004, Nederlands tijdschrift voor geneeskunde.

Clear cell sarcoma (malignant melanoma) of soft parts

J. Peterse, E. Rutgers, A. A. Hart, 1999, Cancer.

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

J. Klijn, A. Broeks, L. J. Veer, 2000, American journal of human genetics.

Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)

H. Putter, E. Rutgers, E. Rutgers, 2018, Journal of the National Cancer Institute.

Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life.

P M Bossuyt, P. Bossuyt, M. Sprangers, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re: Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30(8):807-16.

E. Rutgers, P. Meijnen, 2005, European Journal of Surgical Oncology.

Extensive soft tissue resection with autologous tissue closure for locally recurrent breast cancer: lasting local control and acceptable morbidity.

E. Rutgers, J. Wesseling, N. Russell, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)

C. Boetes, H. D. de Koning, J. Klijn, 2001, Familial Cancer.

Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.

Marie-Christine W. Gast, E. Rutgers, J. Schellens, 2009, Oncology reports.

[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer": an important document, but keep doors to new 'evidence' open].

M. Tuut, E. Rutgers, G. van Tienhoven, 2003, Nederlandsch tijdschrift voor geneeskunde.

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

M. J. van de Vijver, A. Glas, B. Kreike, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.

D. Larsimont, L. J. Veer, S. Mook, 2009, European journal of cancer.

Surgica l experience with intraoperat ive gamma cameras

E. Rutgers, M. Stokkel, R. Olmos, 2016 .

Integrating new imaging modalities in breast cancer management

E. Rutgers, M. Stokkel, R. Olmos, 2016 .

[The role of sentinel node biopsies in the treatment of patients with breast carcinoma].

E. Rutgers, J. Peterse, O. Nieweg, 1996, Nederlands tijdschrift voor geneeskunde.

Sentinel-node biopsy sampling in breast cancer

E. Rutgers, P. Tanis, O. Nieweg, 2000, The Lancet.

Intraoperative hyperthermic intrathoracic perfusion chemotherapy for pleural metastases of thymic neoplasms.

E. Rutgers, F. Zoetmulder, E. de Bree, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?

E. Rutgers, J. Wesseling, C. Loo, 2013, European journal of radiology.